Nuvilex: The Real Story
August 15, 2013 15:20 ET
|
Nuvilex, Inc.
SAN DIEGO, CA--(Marketwired - Aug 15, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, wishes to provide accurate information...
Stock Market Media Group Issues Nuvilex, Inc. Road to Phase III Clinical Trials Report
August 15, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 15, 2013) - Stock Market Media Group, a research and content development investor relations firm, issued its Third Quarter Update and the first installment of its...
Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets With Technology
August 07, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is methodically laying the foundation today for what should be a very busy and promising future tomorrow. After making a...
Nuvilex, Inc. Strengthens Its Hand in the Cancer Arena With Purchase of Assets
July 30, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 30, 2013) - Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for,...
Nuvilex, Inc. Moves Closer to Head to Head With Eli Lilly in Phase III Clinical Trials
July 25, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 25, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is currently preparing the way to challenge Eli Lilly's blockbuster cancer drug, Gemzar, and doing so with the knowledge...
Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions
July 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 18, 2013) - In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century. The company...
Nuvilex, Inc. Returns 100 Million Shares to Company's Treasury After Completing Acquisition
July 16, 2013 09:30 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Jul 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX), (the "Company"), an international biotechnology company and provider of natural products and cell and gene therapy...
Nuvilex, Inc. Will Enter Phase III Trials With Advantages Using Cell Encapsulation
July 09, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 9, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug...
Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics
July 02, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 2, 2013) - While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s...
Nuvilex, Inc. a Biotech Developing Treatments for Healthcare's Hard Targets
June 26, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) executives aren't daunted by the statistics. As a matter of fact, they're aware the research they do is directed...